DERIVES DE CHROMENE UTILISES COMME INHIBITEURS DE L'INTERACTION TCR-NCK

• 收藏
• 分享

专利权人:

ARTAX BIOPHARMA INC.

发明人:

GAGETE MATEOS, ANDRES,CASTRO PALOMINO, JULIO,MARTI CLAUZEL, LUC,TORMO CARULLA, DAMIA

申请号：

CA2925863

公开号：

CA2925863C

申请日:

2014.10.20

申请国别(地区):

CA

年份:

2018

代理人:

摘要：

The invention relates to a group of compounds of formula (I), which contain a chromene nucleus and can inhibit lymphocyte proliferation owing to the TCR-Nck interaction, said invention also relating to the use of these compounds for the treatment of diseases or conditions in which the aforementioned interaction triggers a complication, such as transplant rejection reactions, immune or autoimmune diseases, inflammatory diseases or proliferative diseases.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/